A cross-sectional study of Iraqi patients investigating HPSE SNPs and the incidence of hepatocellular carcinoma

Authors

  • Suhair Sadai Mahmood Ministry of Higher Education and Scientific Research, Medical College, Al-Iraqia University, Baghdad, Iraq
  • Sabah Ali Jaber Alhelu Ministry of Higher Education and Scientific Research, College of Medicine, Jabir Ibn Hayyan Medical University, Al-Najaf, Iraq
  • Khaleel Ibrahim Ismael Department of Clinical Reproductive Physiology, High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Nahrain University, Baghdad, Iraq
  • Abbas AbdulWahhab Jumaah Department of Applied Embryology, High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Nahrain University, Baghdad, Iraq
  • Ban Thabit Saeed Department of Applied Embryology, High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Nahrain University, Baghdad, Iraq
  • Luai Farhan Zghair Ministry of Higher Education and Scientific Research, Surgical Department, Medical College, Al-Iraqia University, Baghdad, Iraq
  • Ali Qais Abdulkafi Iraqi Ministry of Health, Kirkuk Health Department, Kirkuk General Hospital, Kirkuk, Iraq

DOI:

https://doi.org/10.47750/jptcp.2023.1059

Keywords:

Chronic renal failure, Renin , Aspartate Amino Transferase Alanine Amino Transferase , Albumin, Globulin, Calcium , Sodium , Potassium .

Abstract

In this study, 30 cases from different hospitals in Iraq were included, and they were divided into two groups (a patients group of 15 cases) (a control group of 15 cases). Patient groups were divided according to gender, 12 males (80%) and three females (20%) in the patient’s group while five females (33.3%) and 10 males (6.6%) in the control group. Information related to patients was collected within the study period of 14 months (July 1, 2019 to September 2, 2020). The demographic data of the patients were analyzed using the statistical analysis program IBM SOFT SPSS 22, where the true value and the arithmetic mean of the results were calculated, and the value of the statistical significance to know the type of relationship was also extracted. The results found rs 12503843 with HCV (CC for eight patients were distributed, six HCV positive and two negative patients; CT for five patients were distributed, four patients HCV positive and one negative patient; TT for two patients were distributed with two positive patients). As for the distribution of patients according to the results of the statistical relationship between rs 12331678 with HCV (six cc patients were distributed as five positive HCV and one negative; CA for six patients distributed as two negative HCV and four positive HCV). Finally, we concluded in this study; it was described that heparanase (HPSE) (rs 12331678 and rs 12503843) with the incidence of hepatocellular carcinoma, and a statistically significant relationship was found with a p-value < 0.01. 

References

Liu YB, Gao SL, Chen XP, et al. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma. World J Gastroenterol.

; 11: 1378–1381. https://doi.org/10.3748/wjg.v11.i9.1378

Ostrovsky O, Shimoni A, Baryakh P, et al. Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. J Leukoc Biol. 2014; 95: 677–688. https://doi.org/10.1189/jlb.0313147

Zhang H, Zhai Y, Hu Z, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in

chronic hepatitis B virus carriers. Nat Genet. 2010; 42: 755–758. https://doi.org/10.1038/ng.638

Zhai Y, Qiu W, Dong XJ, et al. Functional polymorphisms in the promoters of MMP-1, MMP2, MMP-3, MMP-9, MMP-12, and MMP-13 are

not associated with hepatocellular carcinoma risk. Gut. 2007; 56: 445–447. https://doi.org/10.1136/gut.2006.112706

Yang JM, Wang HJ, Du L, et al. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for

hepatocellular carcinoma. Cancer Immunol Immunother. 2009; 58: 1387–1396. https://doi.org/10.1007/s00262-008-0651-x

Ha NB, Ha NB, Ahmed A, et al. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Contr. 2012; 23: 455–462. https://doi.org/10.1007/s10552-012-9895-z

Zhang Y, Li L, Wang Y, et al. Downregulating the expression of heparanase inhibits the invasion, angiogenesis, and metastasis of human

hepatocellular carcinoma. Biochem Biophys Res Commun. 2007; 358: 124–129. https://doi.org/10.1016/j.bbrc.2007.04.068

Xiao Y, Kleeff J, Shi X, et al. Heparanase expression in hepatocellular carcinoma and the cirrhotic liver. Hepatol Res. 2003; 26: 192–198.

https://doi.org/10.1016/S1386-6346(03)00107-4

Weng CJ, Hsieh YH, Tsai CM, et al. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and

pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010; 17(7): 1808–1815. https://doi.org/10.1245/s10434-009-0904-8

Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893–2917.

https://doi.org/10.1002/ijc.25516

Goldshmidt O, Yeikilis R, Mawasi N, et al. Heparanase expression during normal liver development and following partial hepatectomy. J

Pathol. 2004; 203: 594–602. https://doi.org/10.1002/path.1554

Yano Y, Yamashita F, Kuwaki K, et al. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with 훼-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver Int. 2006; 26: 789–795. https://doi.org/10.1111/j.1478-3231.2006.01310.x

Chen G, Dang YW, Luo DZ, et al. Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study. Oncol Res. 2008; 17: 183–189. https://doi.org/10.3727/096504008785114138

Ralph S, Brenchley PE, Summers A, et al. Heparanase gene haplotype (CGC) is associated with the stage of disease in patients with ovarian

carcinoma. Cancer Sci. 2007; 98: 844–849. https://doi.org/10.1111/j.1349-7006.2007.00461.x

Sasisekharan R, Shriver Z, Venkataraman G, et al. Roles of heparan-sulfate glycosaminoglycans in cancer. Nat Rev Cancer. 2002; 2: 521–528.

https://doi.org/10.1038/nrc842

Downloads

Published

2023-02-06

How to Cite

Suhair Sadai Mahmood, Sabah Ali Jaber Alhelu, Khaleel Ibrahim Ismael, Abbas AbdulWahhab Jumaah, Ban Thabit Saeed, Luai Farhan Zghair, & Ali Qais Abdulkafi. (2023). A cross-sectional study of Iraqi patients investigating HPSE SNPs and the incidence of hepatocellular carcinoma. Journal of Population Therapeutics and Clinical Pharmacology, 30(1), 258-267. https://doi.org/10.47750/jptcp.2023.1059
More Citation Formats

Issue

Section

Articles

How to Cite

Suhair Sadai Mahmood, Sabah Ali Jaber Alhelu, Khaleel Ibrahim Ismael, Abbas AbdulWahhab Jumaah, Ban Thabit Saeed, Luai Farhan Zghair, & Ali Qais Abdulkafi. (2023). A cross-sectional study of Iraqi patients investigating HPSE SNPs and the incidence of hepatocellular carcinoma. Journal of Population Therapeutics and Clinical Pharmacology, 30(1), 258-267. https://doi.org/10.47750/jptcp.2023.1059

Most read articles by the same author(s)